Canada markets open in 5 hours 47 minutes
  • S&P/TSX

    19,228.03
    -0.87 (-0.00%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • CAD/USD

    0.7961
    -0.0023 (-0.29%)
     
  • CRUDE OIL

    58.86
    -0.46 (-0.78%)
     
  • BTC-CAD

    76,579.45
    +1,279.23 (+1.70%)
     
  • CMC Crypto 200

    1,315.55
    +88.01 (+7.17%)
     
  • GOLD FUTURES

    1,739.30
    -5.50 (-0.32%)
     
  • RUSSELL 2000

    2,243.47
    +0.87 (+0.04%)
     
  • 10-Yr Bond

    1.6660
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,806.00
    -23.50 (-0.17%)
     
  • VOLATILITY

    17.45
    +0.50 (+2.95%)
     
  • FTSE

    6,877.61
    -38.14 (-0.55%)
     
  • NIKKEI 225

    29,538.73
    -229.33 (-0.77%)
     
  • CAD/EUR

    0.6698
    -0.0006 (-0.09%)
     

X4 Pharmaceuticals: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

BOSTON (AP) _ X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $18.4 million in its fourth quarter.

The Boston-based company said it had a loss of 91 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 87 cents per share.

For the year, the company reported that its loss widened to $62.1 million, or $3.09 per share. Revenue was reported as $3 million.

X4 Pharmaceuticals shares have risen 51% since the beginning of the year. The stock has declined nearly 8% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR